Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Zoetis Inc

Act Fast! These Buy Rated Companies Just Crossed Over Above Its 200-Day SMA!

While Wall Street shows signs of caution, these 3 buy-rated stocks quietly crossed above their 200-Day SMA.

Barchart

Zoetis's Wetteny Joseph—one of the few Black CFOs in the Fortune 500—began his journey to finance chief in Haiti

Joseph shares his personal journey, discusses why representation matters, and explains what specific steps landed him in the C-suite.

Fortune

4 Pharma Stocks to Buy Now for the Long Haul

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

1 Medical Stock to Get Bullish on Right Now

Medical stock Zoetis (ZTS) has witnessed steady growth despite the market turbulence in the past few months. Moreover, Wall Street analysts expect the stock to soar further. So, considering its robust fundamentals, ZTS might be worth buying now. Keep reading.

StockNews.com

3 Pharmaceutical Stocks to Invest in This Month

The pharmaceutical industry is rapidly evolving to meet today’s health challenges. The pharmaceutical industry's long-term prospects look bright with a globally aging population set to increase healthcare expenditure. Moreover, given the industry’s ability to stay resilient amid economic headwinds, it could be wise to invest in fundamentally strong pharmaceutical stocks…

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

StockNews.com

2 Stocks That Have Been Boosting Their Dividends Lately

Market volatility is widespread due to increasing odds of a recession amid the persistently high inflation and consecutive interest rate hikes by the Fed. Traders are betting on another aggressive hike this month as the Fed stays determined to bring inflation under control. Thus, we think investors should invest in…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Best Recession-Proof Stocks to Invest in Right Now

As the possibility of the Fed maintaining its hawkish stance to tame the elevated inflation is raising concerns over a potential recession, it could be wise to invest in defensive stocks Dollar Tree (DLTR), UnitedHealth Group (UNH), and Zoetis (ZTS) to make your portfolio recession-proof. Keep reading….

StockNews.com

CNBC's Final Trades: ChargePoint Holdings, Energy Puts, And These Pharma And Health Care Stocks To Buy

On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is a pharma company “without all the problems

Benzinga

CNBC's Final Trades: Zoetis, VanEck Gold Miners ETF, Paramount Global And This Energy Stock

On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is “the largest provider of vaccines and medicines for pets and live

Benzinga

3 Pet Stocks to Buy and Hold in 2022

Despite rising pet care costs amid the Russia-Ukraine war and record-high inflation, the demand for pet care products remains strong. And because a significant increase in pet ownership amid the COVID-19 pandemic is expected to keep the demand high, we think it could be wise to scoop up shares of…

StockNews.com

Add These 4 No-Brainer Stocks Down More than 20% to Your Portfolio

Due to the increasing sanctions on Russia, inflationary pressures, and supply chain disruptions, the stock market has been exhibiting high volatility. However, quality stocks Zoetis (ZTS), Accenture (ACN), Micron Technology (MU), and QUALCOMM (QCOM), which declined more than 20% year-to-date, have the potential to rebound quickly. So, these stocks could…

StockNews.com

Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook

Zoetis Inc (NYSE: ZTS) has reported Q4 FY21 revenue of $2 b

Benzinga

1 2

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

ACN

112 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.